Iver­ic, Astel­las eye US la­bel ex­pan­sion for ge­o­graph­ic at­ro­phy drug af­ter pos­i­tive two-year da­ta

Iver­ic Bio and Astel­las Phar­ma’s Iz­er­vay has shown longer-term ef­fi­ca­cy promise in ge­o­graph­ic at­ro­phy (GA), paving the way for a US la­bel ex­pan­sion aimed at …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER